Emily Briggs

441 total citations
25 papers, 310 citations indexed

About

Emily Briggs is a scholar working on Epidemiology, Infectious Diseases and Genetics. According to data from OpenAlex, Emily Briggs has authored 25 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Infectious Diseases and 4 papers in Genetics. Recurrent topics in Emily Briggs's work include Microscopic Colitis (6 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Inflammatory Bowel Disease (4 papers). Emily Briggs is often cited by papers focused on Microscopic Colitis (6 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Inflammatory Bowel Disease (4 papers). Emily Briggs collaborates with scholars based in United States, United Kingdom and Thailand. Emily Briggs's co-authors include Richard S. Tedder, Ian Weller, Brian Gazzard, A J Pinching, Jan Weber, Michael Adler, R. Cheingsong‐Popov, J. A. J. Barbara, Angus Dalgleish and Charles Farthing and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Emily Briggs

25 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Briggs United States 9 108 91 89 72 64 25 310
Alfredo García‐Sáiz Spain 12 60 0.6× 134 1.5× 71 0.8× 51 0.7× 45 0.7× 17 274
Luiza Keiko Matsuka Oyafuso Brazil 13 236 2.2× 201 2.2× 167 1.9× 56 0.8× 100 1.6× 29 606
Erica Silberstein United States 12 77 0.7× 104 1.1× 155 1.7× 64 0.9× 9 0.1× 18 421
Megan E. Laycock United States 10 110 1.0× 412 4.5× 123 1.4× 80 1.1× 55 0.9× 14 612
Agnès Petit‐Camurdan France 8 106 1.0× 161 1.8× 87 1.0× 23 0.3× 22 0.3× 9 352
Alexander Kotelkin United States 7 83 0.8× 197 2.2× 148 1.7× 16 0.2× 59 0.9× 8 357
A Pesce Italy 13 23 0.2× 102 1.1× 37 0.4× 99 1.4× 18 0.3× 40 389
Takuji Kumagai Japan 12 78 0.7× 255 2.8× 115 1.3× 11 0.2× 24 0.4× 25 411
Guido Palamara Italy 15 41 0.4× 296 3.3× 263 3.0× 19 0.3× 198 3.1× 27 549
Lewis W. Marshall United States 8 108 1.0× 38 0.4× 80 0.9× 31 0.4× 9 0.1× 19 332

Countries citing papers authored by Emily Briggs

Since Specialization
Citations

This map shows the geographic impact of Emily Briggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Briggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Briggs more than expected).

Fields of papers citing papers by Emily Briggs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Briggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Briggs. The network helps show where Emily Briggs may publish in the future.

Co-authorship network of co-authors of Emily Briggs

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Briggs. A scholar is included among the top collaborators of Emily Briggs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Briggs. Emily Briggs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Briggs, Emily, Mohamed Kamal, Matthew P. Kosloski, et al.. (2023). Integrated Exposure–Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis. Pharmaceutical Research. 40(11). 2653–2666. 1 indexed citations
2.
3.
Briggs, Emily, et al.. (2023). A Sustainable, Green-Processed, Ag-Nanoparticle-Incorporated Eggshell-Derived Biomaterial for Wound-Healing Applications. Journal of Functional Biomaterials. 14(9). 450–450. 11 indexed citations
4.
Briggs, Emily & Jacqui Smith. (2023). FEELING YOU BELONG: THE EFFECTS OF COMMUNITY INVOLVEMENT ON WELL-BEING IN LATER LIFE. Innovation in Aging. 7(Supplement_1). 845–845. 1 indexed citations
5.
Shen, Guoxiang, Emily Briggs, Ryan L. Crass, et al.. (2023). Population pharmacokinetic and exposure-response safety analyses of mecbotamab vedotin (BA3011) in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). e15010–e15010. 1 indexed citations
6.
Limsrivilai, Julajak, Laura A. Johnson, Ryan W. Stidham, et al.. (2020). Prevalence and Effect of Intestinal Infections Detected by a PCR-Based Stool Test in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 65(11). 3287–3296. 17 indexed citations
7.
Briggs, Emily, et al.. (2020). Hyponatraemia compounding pre-eclamptic toxaemia in a patient with type 1 diabetes. BMJ Case Reports. 13(9). e236511–e236511. 1 indexed citations
8.
Limsrivilai, Julajak, Krishna Rao, Ryan W. Stidham, et al.. (2018). Systemic Inflammatory Responses in Ulcerative Colitis Patients and Clostridium difficile Infection. Digestive Diseases and Sciences. 63(7). 1801–1810. 7 indexed citations
9.
Limsrivilai, Julajak, Laura E. Johnson, Ryan W. Stidham, et al.. (2018). P086 OVER 30% OF SYMPTOMATIC FLARES IN INFLAMMATORY BOWEL DISEASE PATIENTS ARE ASSOCIATED WITH DETECTABLE GASTROINTESTINAL INFECTIOUS AGENTS BY THE BIOFIRE GI PCR PANEL STOOL TEST. Gastroenterology. 154(1). S44–S45. 1 indexed citations
10.
Black, Donald M., Darren Bentley, Sunny Chapel, et al.. (2018). Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib. Clinical Pharmacokinetics. 57(11). 1359–1367. 13 indexed citations
11.
12.
Limsrivilai, Julajak, Krishna Rao, Ryan W. Stidham, et al.. (2017). The Systemic Inflammatory Response to Clostridium Difficile Infection (CDI) in Patients with Ulcerative Colitis. Gastroenterology. 152(5). S760–S760. 3 indexed citations
13.
Limsrivilai, Julajak, Ryan W. Stidham, Akbar K. Waljee, et al.. (2017). Gastrointestinal Infectious Agents Detected by Biofire Filmarray GI PCR Panel Stool Testing in Active Inflammatory Bowel Disease are Common and are Associated with a More Benign Course of IBD. Gastroenterology. 152(5). S606–S606. 1 indexed citations
14.
Brink, Nicola S., Rajesh Chopra, C. Ring, et al.. (1993). Acute hepatitis C infection in patients undergoing therapy for haematological malignancies: a clinical and virological study. British Journal of Haematology. 83(3). 498–503. 19 indexed citations
15.
Cheingsong‐Popov, R., Richard Weiss, Angus Dalgleish, et al.. (1984). PREVALENCE OF ANTIBODY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE III IN AIDS AND AIDS-RISK PATIENTS IN BRITAIN. The Lancet. 324(8401). 477–480. 162 indexed citations
16.
McFerran, J.B., D. S. Dane, Emily Briggs, Tim Connor, & R. Nelson. (1968). Further investigations on enterovirus‐neutralising substances in human and animal sera. The Journal of Pathology and Bacteriology. 95(1). 93–99. 8 indexed citations
17.
Haire, Margaret, et al.. (1966). Further studies with a diphtheria–tetanus–poliomyelitis vaccine. Epidemiology and Infection. 64(4). 485–488. 2 indexed citations
18.
Briggs, Emily, et al.. (1962). NEW QUADRUPLE VACCINE. The Lancet. 279(7236). 939–941. 8 indexed citations
19.
Briggs, Emily, et al.. (1957). The Effect of Delay on the Estimation of the ‘Prothrombin Time’. Scottish Medical Journal. 2(7). 284–287. 3 indexed citations
20.
Briggs, Emily, et al.. (1956). POLIOVIRUS ANTIBODY IN CHILDREN IN NORTHERN IRELAND. The Lancet. 267(6921). 481–483. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfredo García‐Sáiz Breakdown of academic impact, for papers by Luiza Keiko Matsuka Oyafuso Breakdown of academic impact, for papers by Erica Silberstein Breakdown of academic impact, for papers by Megan E. Laycock Breakdown of academic impact, for papers by Agnès Petit‐Camurdan Breakdown of academic impact, for papers by Alexander Kotelkin Breakdown of academic impact, for papers by A Pesce Breakdown of academic impact, for papers by Takuji Kumagai Breakdown of academic impact, for papers by Guido Palamara Breakdown of academic impact, for papers by Lewis W. Marshall
Rankless by CCL
2026